A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C
Public ClinicalTrials.gov record NCT01482390. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Multicenter, Parallel Group Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug RO5024048 in Combination With Telaprevir and Pegasys®/Copegus® in Patients With Chronic Hepatitis C Genotype 1 Virus Infection Who Were Prior Null Responders to Treatment With Pegylated Interferon/Ribavirin
Study identification
- NCT ID
- NCT01482390
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- Ribavirin Drug
- Mericitabine Drug
- Peginterferon Alfa-2a Drug
- Placebo Drug
- Telaprevir Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 29, 2011
- Primary completion
- Jan 30, 2014
- Completion
- Jan 30, 2014
- Last update posted
- Apr 23, 2017
2011 – 2014
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Gastro Associates, P.C. | Birmingham | Alabama | 35209 | — |
| VA Long Beach Healthcare System | Long Beach | California | 90822 | — |
| Kaiser Permanente Sacramento Medical Center | Sacramento | California | 95825 | — |
| UCSD Antiviral Research Center | San Diego | California | 92103 | — |
| Yale University | New Haven | Connecticut | 06510 | — |
| Gastroenterology Group of Naples | Naples | Florida | 34102 | — |
| John Hopkins Hospital | Lutherville | Maryland | 21093 | — |
| Metrowest Medical Center | Framingham | Massachusetts | 01702 | — |
| Saint Louis University Gastroenterology & Hepatology; Clinical Research Unit | St Louis | Missouri | 63104 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Carolina'S Center For Liver Disease | Statesville | North Carolina | 28677 | — |
| Uni of Cincinnati College of Medicine; Div. of Digestive Diseases | Cincinnati | Ohio | 45267-0595 | — |
| Baylor Uni Medical Center; Division Of Hepatology/Transplantation; Annette C. and Harold C. Simmons | Dallas | Texas | 75246 | — |
| McGuire; Veteran Affairs Med Ctr | Richmond | Virginia | 23249 | — |
| Harborview Medical Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01482390, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2017 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01482390 live on ClinicalTrials.gov.